Biotherapeutics News and Research

RSS
New live cell models lay the groundwork for studies into mitochondrial diseases

New live cell models lay the groundwork for studies into mitochondrial diseases

Latest ATS/CSL Behring research grant recipient focuses on COVID-19 ARDS study

Latest ATS/CSL Behring research grant recipient focuses on COVID-19 ARDS study

Enzyme inhibitor boosts immune system to fight MRSA and other dangerous skin infections

Enzyme inhibitor boosts immune system to fight MRSA and other dangerous skin infections

An oral pill for COVID-19? Molnupiravir shows promise

An oral pill for COVID-19? Molnupiravir shows promise

FDA approves new treatment for patients with hypoplasminogenemia

FDA approves new treatment for patients with hypoplasminogenemia

Researchers report promising biotherapeutics for obesity and related medical complications

Researchers report promising biotherapeutics for obesity and related medical complications

Nanotechnology and COVID-19 diagnosis and treatment

Nanotechnology and COVID-19 diagnosis and treatment

Study reveals how oral antiviral drug works to attack SARS-CoV-2 virus

Study reveals how oral antiviral drug works to attack SARS-CoV-2 virus

Nanoscope presents optical gene delivery, OCT-guided electrophysiology platforms at ARVO annual meeting

Nanoscope presents optical gene delivery, OCT-guided electrophysiology platforms at ARVO annual meeting

Repairing faulty drains could be key to unlocking the potential of Alzheimer's therapies

Repairing faulty drains could be key to unlocking the potential of Alzheimer's therapies

NIH to conduct large trial for COVID-19 polyclonal antibody therapies

NIH to conduct large trial for COVID-19 polyclonal antibody therapies

Experimental antiviral drug for COVID-19 shows effectiveness in hamster models

Experimental antiviral drug for COVID-19 shows effectiveness in hamster models

Gyros Protein Technologies introduces Gyrolab Bioaffy 4000 CD to extend sensitivity of immunoassay CD range

Gyros Protein Technologies introduces Gyrolab Bioaffy 4000 CD to extend sensitivity of immunoassay CD range

Horizon Discovery licenses CHOSOURCE to Sanyou Biopharmaceuticals Co.

Horizon Discovery licenses CHOSOURCE to Sanyou Biopharmaceuticals Co.

Researchers successfully edit SIV virus from genomes of non-human primates

Researchers successfully edit SIV virus from genomes of non-human primates

Unique training program is bolstering Canada’s capacity to manufacture novel biotherapeutics

Unique training program is bolstering Canada’s capacity to manufacture novel biotherapeutics

Stewart Kay joins Adaptate Biotherapeutics as Chief Business Officer

Stewart Kay joins Adaptate Biotherapeutics as Chief Business Officer

New DNA-cutting tool could advance gene editing for novel treatments

New DNA-cutting tool could advance gene editing for novel treatments

Novel microfluidic approach to fight cancer could greatly benefit patients

Novel microfluidic approach to fight cancer could greatly benefit patients

Immunotherapy benefits patients with gastric and esophageal cancers, new data shows

Immunotherapy benefits patients with gastric and esophageal cancers, new data shows